|
1
|
Graft-versus-myeloma effect in two cases.
|
Lancet
|
1996
|
1.80
|
|
2
|
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft.
|
Blood
|
1994
|
1.39
|
|
3
|
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
|
Blood
|
1997
|
0.98
|
|
4
|
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
|
Bone Marrow Transplant
|
1993
|
0.83
|
|
5
|
A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants.
|
Clin Infect Dis
|
1997
|
0.81
|
|
6
|
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
|
Bone Marrow Transplant
|
1998
|
0.81
|
|
7
|
Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation.
|
Blood
|
1991
|
0.81
|
|
8
|
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
|
Cancer Res
|
1990
|
0.80
|
|
9
|
Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
|
Bone Marrow Transplant
|
1996
|
0.79
|
|
10
|
Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission.
|
J Clin Oncol
|
1992
|
0.78
|
|
11
|
Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
|
J Clin Oncol
|
1992
|
0.77
|
|
12
|
Bone marrow transplantation with a fixed low number of T-cells in the graft.
|
Haematol Blood Transfus
|
1990
|
0.75
|